<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR115">
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Khanal</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Vausselin</surname>
    <given-names>T</given-names>
   </name>
   <name>
    <surname>Barras</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Bande</surname>
    <given-names>O</given-names>
   </name>
   <name>
    <surname>Turcheniuk</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Benazza</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Zaitsev</surname>
    <given-names>V</given-names>
   </name>
   <name>
    <surname>Teodorescu</surname>
    <given-names>CM</given-names>
   </name>
   <name>
    <surname>Boukherroub</surname>
    <given-names>R</given-names>
   </name>
   <name>
    <surname>Siriwardena</surname>
    <given-names>A</given-names>
   </name>
   <name>
    <surname>Dubuisson</surname>
    <given-names>J</given-names>
   </name>
   <name>
    <surname>Szunerits</surname>
    <given-names>S</given-names>
   </name>
  </person-group>
  <article-title>Phenylboronic-acid-modified nanoparticles: potential antiviral therapeutics</article-title>
  <source>ACS Appl Mater Interfaces</source>
  <year>2013</year>
  <volume>5</volume>
  <fpage>12488</fpage>
  <lpage>12498</lpage>
  <pub-id pub-id-type="doi">10.1021/am403770q</pub-id>
  <?supplied-pmid 24180242?>
  <pub-id pub-id-type="pmid">24180242</pub-id>
 </element-citation>
</ref>
